Flu Mist Ingredients

The data sheet lists 3 types of live flu virus, monosodium glutamate, porcine gelatine (pig bones), sucrose, dibasic potassium phosphate, monosodium phosphate, gentamicin.

Adverse Reactions To Flu Mist Nasal Spray Vaccine

In children aged 6-23 months, wheezing requiring bronchodilator therapy or with significant respiratory symptoms occured in 5.9% of flu mist recipients, compared with 3.8% of the control.

(It wasn’t a real control as according to the data sheet the control had been given an injectable flu vaccine by Sanofi Pasteur, rather than a harmless sugar pill or nothing at all).

Hypersensitivity, including anaphylactic shock has occured post-marketing.

Percentages Of Children With Hospitalisations And Cases Of Wheezing After Flu Vaccines

In babies aged 6-23 months: there were 4.2% who required hospitalisation after flu mist vaccine spray and 3.2% after injectable flu vaccine.

In children aged 24-59 months there were 2.1% who required hospitalisation after flu mist vaccine spray and 2.5% after injectable flu vaccine.

In babies aged 6-23 months there were 5.9% who suffered wheezing after flu mist vaccine spray and 3.8% after injectable flu vaccine.

In children aged 24-59 months there were 2.1% who suffered wheezing after flu mist vaccine spray and 2.5% after injectable flu vaccine.

Adverse Events Occuring Within 10 days after dose 1 of vaccine or control vaccine

Runny nose/nasal congestion:

51% of children vaccinated with flu mist vaccine spray and 42% of children vaccinated with injectable flu vaccine developed runny nose/nasal congestion.

13% of children vaccinated with flu mist vaccine spray and 12% of children vaccinated with injectable flu vaccine suffered decrease in appetite.

12% of children vaccinated with flu mist vaccine spray and 11% of children vaccinated with injectable flu vaccine suffered irritability.

7% of children vaccinated with flu mist vaccine spray and 6% of children vaccinated with injectable flu vaccine suffered lethargy (decrease in activity).

5% of children vaccinated with flu mist vaccine spray and 6% of children vaccinated with injectable flu vaccine suffered sore throat.

3% of children vaccinated with flu mist vaccine spray and 3% of children vaccinated with injectable flu vaccine developed headaches.

2% of children vaccinated with flu mist vaccine spray and 2% of children vaccinated with injectable flu vaccine developed chills and muscle aches.

6% of children vaccinated with flu mist vaccine spray and 4% of children vaccinated with injectable flu vaccine had a fever of 100-101 F

4% of children vaccinated with flu mist vaccine spray and 3% of children vaccinated with injectable flu vaccine had a fever of 101-102 F.

Adverse Events In Adults

A trial was conducted on adults aged 18-49, but it wasn’t a true scientific trial as the placebo was flu mist as well!

The control group had regular refridgerated flu mist and the placebo had FROZEN flu mist.

44% of adults vaccinated with flu mist vaccine spray and 27% vaccinated with the frozen variety experienced runny nose.

40% of adults vaccinated with flu mist vaccine spray and 38% vaccinated with the frozen variety developed headache.

28% of adults vaccinated with flu mist vaccine spray and 17% vaccinated with the frozen variety developed sore throat.

26% of adults vaccinated with flu mist vaccine spray and 22% vaccinated with the frozen variety suffered from weakness and tiredness.

17% of adults vaccinated with flu mist vaccine spray and 15% vaccinated with the frozen variety developed muscle aches.

14% of adults vaccinated with flu mist vaccine spray and 11% vaccinated with the frozen variety got a cough.

9% of adults vaccinated with flu mist vaccine spray and 6% vaccinated with the frozen variety developed chills.

Other Adverse Reactions Post-Trial

Exacerbation of mitochondrial encephalomyopathy, gastrointestinal disorders – nausea, vomiting and diarrhoea.

Immune system disorders, hypersensitivity reactions, anaphylactic shock, facial edema, urticaria.

Nervous system disorders, Guillain-Barre Syndrome, Bell’s Palsy.

Respiratory, thoracic, and mediastinal disorders, epistaxis.

Skin and subcutaneous tissue disorders, rash.

Contraindications To Flu Mist Vaccine Spray

You shouldn’t be vaccinated if:

1. You have a history of anaphylactic shock after vaccines.

2. Allergy to egg or egg proteins.

3. Allergy to gentamicin (antibiotic).

4. Allergy to gelatine or arginine or with life threatening reactions to previous flu vaccines.

5. Children aged 2-17 who are taking asprin should not have flu vaccine because of the risk of Reyes Syndrome.

6. Flu mist should not be administered to any individuals with asthma.

7. It should not be given to children under the age of 5 who have a history of recurrent wheezing.

8. It should not be given to anyone with an underlying illness or disorder.

9. Administration of flu mist, a live virus vaccine, to immuno-compromised individuals should be based on careful consideration of the benefits and risks.

(VAN UK’S COMMENT: In all other medical documents we have read, live vaccines are absolutely contraindicated in immuno-suppressed people).

10. If you have had Guillain-Barre Syndrome within 6 weeks of a previous vaccination, flu mist should only be given based on careful consideration of the benefits and risks.

(This is because there is a higher rate of Guillain-Barre Syndrome cases occuring after flu vaccination).

Non-Clinical Toxicology of Flu Mist

Flu mist vaccine has not been evaluated for it’s carcinogenic or mutagenic properties or it’s potiential to impair fertility (ie, they haven’t studied whether it causes cancer, can mutate into other illnesses or cause infertility).

It is not known whether the flu mist is excreted in human milk. There is a possibility of shedding of vaccine virus. Care should be taken with nursing mothers and infants.

It is not known whether flu mist can cause fetal harm or affect reproduction capacity.

Use of Flu Mist Vaccine In People Over 65

Flu mist is not indicated in this age group.

Subjects in this age group who had underlying medical conditions which would predispose them to the risks of flu, were studied for safety and they were found to have much higher rates of sore throat after vaccination.

It is also not indicated in people aged 50-64 because it is not effective in that age group.

Flu Vaccine Doesn’t Work In The Elderly

Influenza vaccines may save fewer elderly people’s lives than generally claimed.

The reason is that estimates of a 50% or greater reduction in all-cause mortality have emerged from cohort studies fraught with selection bias, asserted a review article in the October issue of The Lancet Infectious Diseases.

But the real effect with flu shots for those 65 and older during December through March could not have been any greater than 5% to 10%, said Lone Simonsen, Ph.D., of George Washington University here, and colleagues. That’s the flu-related mortality burden found in studies of excess all-cause mortality.

Aside from these cohort studies, the evidence is too weak to show any mortality benefit in older adults, who account for 90% of influenza deaths each year, Dr. Simonsen and colleagues added.

Vaccination policies may need to be revisited, commented Tom Jefferson, M.D., and Carlo Di Pietrantonj, Ph.D., both of the Cochrane Vaccines Field in Alessandria, Italy.

“We must never again allow layers of poor research to mask substantial uncertainty about the effects of a public-health intervention and present a falsely optimistic view of policy,” they wrote. They called for placebo-controlled trials.

The “illusory” estimates arose primarily from methodologically weak cohort studies, the GWU researchers said.

These studies used nonspecific endpoints, typically all-cause mortality and non-laboratory-confirmed influenza outcomes, while attempting to adjust for selection bias in multivariate models with health-status covariates defined by diagnostic codes.

Source: Medpage Today, 25 September 2007.
Studies cited were:

Simonsen L, et al “Mortality benefits of influenza vaccination in elderly people: an ongoing controversy” Lancet Infect Dis 2007; 7: 658-66.

Jefferson T, Di Pietrantonj C “Inactivated influenza vaccines in the elderly-are you sure?” Lancet Infect Dis 2007; 7: DOI:10.1016/S0140-6736(07)61389-0.

It should be noted that 90% of the flu death rate is in people over 65 years of age, when the vaccine is not effective anyway

Summary of Flu Mist Spray Vaccine

1.The flu viruses in the spray vaccine are live. As well as live viruses it contains antibiotics which depress the immune system, harmful food additives and pig bones, making it unsuitable for vegetarians.

2. 4.2% of children vaccinated are hospitalized with breathing difficulty and upto 5.9% have wheezing.

3. The flu vaccine (both mist and injection) has side-effects identical to flu and other affects more serious than flu, in both adults and children.

4. The flu mist spray has a rate of side-effects higher than the injection.

5. The flu mist spray can cause anaphylactic shock and death.

6. The flu mist spray can trigger Guillain-Barre Syndrome, a paralysing disease.

7. It is not known whether flu mist spray causes cancer, affects unborn babies, mutates into other illnesses or causes infertility.

8. There has never been a placebo-controlled, double blinded trial of any flu vaccine to see if it works.

9. The flu vaccine is ineffective in the elderly – the very group who are at heightened risk from flu.

10. 60% of doctors and nurses refuse to get the flu shot or spray and many think it does not work, yet they still recommend it to the public.